Hm Payson & CO Veracyte, Inc. Transaction History

Hm Payson & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$32.94 - $56.62 $12,616 - $21,685	-383 Closed	0 $0
Q1 2021 Jun 15, 2021	SELL	$44.47 - $81.38 $10,628 - $19,449	-239 Reduced 38.42%	383 $21,000
Q4 2020 Mar 10, 2021	SELL	$32.49 - $61.88 $5,523 - $10,519	-170 Reduced 21.46%	622 $30,000
Q3 2020 Dec 21, 2020	BUY	$26.73 - $35.67 $21,170 - $28,250	792 New	792 $26,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.